These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

842 related items for PubMed ID: 16029196

  • 1. Autoradiographic mapping of dopamine-D2/D3 receptor stimulated [35S]GTPgammaS binding in the human brain.
    Sóvágó J, Makkai B, Gulyás B, Hall H.
    Eur J Neurosci; 2005 Jul; 22(1):65-71. PubMed ID: 16029196
    [Abstract] [Full Text] [Related]

  • 2. G protein activation by human dopamine D3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5'-O-(3-[35S]thio)- triphosphate binding and antibody study.
    Newman-Tancredi A, Cussac D, Audinot V, Pasteau V, Gavaudan S, Millan MJ.
    Mol Pharmacol; 1999 Mar; 55(3):564-74. PubMed ID: 10051542
    [Abstract] [Full Text] [Related]

  • 3. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
    Newman-Tancredi A, Audinot V, Chaput C, Verrièle L, Millan MJ.
    J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553
    [Abstract] [Full Text] [Related]

  • 4. Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5'-O-(gamma-thiotriphosphate) binding in rat striatal membranes.
    Odagaki Y, Toyoshima R.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep 30; 30(7):1304-12. PubMed ID: 16824659
    [Abstract] [Full Text] [Related]

  • 5. Dopamine D2 receptor-mediated G-protein activation in rat striatum: functional autoradiography and influence of unilateral 6-hydroxydopamine lesions of the substantia nigra.
    Newman-Tancredi A, Cussac D, Brocco M, Rivet JM, Chaput C, Touzard M, Pasteau V, Millan MJ.
    Brain Res; 2001 Nov 30; 920(1-2):41-54. PubMed ID: 11716810
    [Abstract] [Full Text] [Related]

  • 6. Autoradiographic characterisation of [35S]GTPgammaS binding stimulation mediated by 5-HT1B receptor in postmortem human brain.
    Mostany R, Pazos A, Castro ME.
    Neuropharmacology; 2005 Jan 30; 48(1):25-33. PubMed ID: 15617724
    [Abstract] [Full Text] [Related]

  • 7. Catecholaminergic activation of G-protein coupling in rat spinal cord: further evidence for the existence of dopamine and noradrenaline receptors in spinal grey and white matter.
    Venugopalan VV, Ghali Z, Sénécal J, Reader TA, Descarries L.
    Brain Res; 2006 Jan 27; 1070(1):90-100. PubMed ID: 16423330
    [Abstract] [Full Text] [Related]

  • 8. In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.
    Glennon JC, Van Scharrenburg G, Ronken E, Hesselink MB, Reinders JH, Van Der Neut M, Long SK, Feenstra RW, McCreary AC.
    Synapse; 2006 Dec 15; 60(8):599-608. PubMed ID: 17001660
    [Abstract] [Full Text] [Related]

  • 9. Differential effects on [35S]GTPgammaS binding using muscarinic agonists and antagonists in the gerbil brain.
    Pilar-Cuéllar F, Paniagua MA, Mostany R, Pérez CC, Fernández-López A.
    J Chem Neuroanat; 2005 Oct 15; 30(2-3):119-28. PubMed ID: 16095872
    [Abstract] [Full Text] [Related]

  • 10. S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: I. Cellular, electrophysiological, and neurochemical profile in comparison with ropinirole.
    Millan MJ, Cussac D, Gobert A, Lejeune F, Rivet JM, Mannoury La Cour C, Newman-Tancredi A, Peglion JL.
    J Pharmacol Exp Ther; 2004 Jun 15; 309(3):903-20. PubMed ID: 14978194
    [Abstract] [Full Text] [Related]

  • 11. Agonist and inverse agonist activity at the dopamine D3 receptor measured by guanosine 5'--gamma-thio-triphosphate--35S- binding.
    Malmberg, Mikaels, Mohell N.
    J Pharmacol Exp Ther; 1998 Apr 15; 285(1):119-26. PubMed ID: 9536001
    [Abstract] [Full Text] [Related]

  • 12. S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride.
    Millan MJ, Newman-Tancredi A, Brocco M, Gobert A, Lejeune F, Audinot V, Rivet JM, Schreiber R, Dekeyne A, Spedding M, Nicolas JP, Peglion JL.
    J Pharmacol Exp Ther; 1998 Oct 15; 287(1):167-86. PubMed ID: 9765336
    [Abstract] [Full Text] [Related]

  • 13. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
    Cosi C, Carilla-Durand E, Assié MB, Ormiere AM, Maraval M, Leduc N, Newman-Tancredi A.
    Eur J Pharmacol; 2006 Mar 27; 535(1-3):135-44. PubMed ID: 16554049
    [Abstract] [Full Text] [Related]

  • 14. Signal transduction pathway activity compensates dopamine D₂/D₃ receptor density changes in Parkinson's disease: a preliminary comparative human brain receptor autoradiography study with [³H]raclopride and [³⁵S]GTPγS.
    Farkas S, Nagy K, Jia Z, Hortobágyi T, Varrone A, Halldin C, Csiba L, Gulyás B.
    Brain Res; 2012 May 09; 1453():56-63. PubMed ID: 22480734
    [Abstract] [Full Text] [Related]

  • 15. Evidence for the coupling of Gq protein to D1-like dopamine sites in rat striatum: possible role in dopamine-mediated inositol phosphate formation.
    Wang HY, Undie AS, Friedman E.
    Mol Pharmacol; 1995 Dec 09; 48(6):988-94. PubMed ID: 8848015
    [Abstract] [Full Text] [Related]

  • 16. Subchronic haloperidol increases CB(1) receptor binding and G protein coupling in discrete regions of the basal ganglia.
    Andersson M, Terasmaa A, Fuxe K, Strömberg I.
    J Neurosci Res; 2005 Oct 15; 82(2):264-72. PubMed ID: 16175569
    [Abstract] [Full Text] [Related]

  • 17. Sex differences in dopamine D2-like receptor-mediated G-protein activation in the medial prefrontal cortex after cocaine.
    Sun WL, Festa ED, Jenab S, Quinones-Jenab V.
    Ethn Dis; 2010 Oct 15; 20(1 Suppl 1):S1-88-91. PubMed ID: 20521392
    [Abstract] [Full Text] [Related]

  • 18. [3H]-quinelorane binds to D2 and D3 dopamine receptors in the rat brain.
    Gackenheimer SL, Schaus JM, Gehlert DR.
    J Pharmacol Exp Ther; 1995 Sep 15; 274(3):1558-65. PubMed ID: 7562534
    [Abstract] [Full Text] [Related]

  • 19. The influence of G protein subtype on agonist action at D2 dopamine receptors.
    Nickolls SA, Strange PG.
    Neuropharmacology; 2004 Nov 15; 47(6):860-72. PubMed ID: 15527820
    [Abstract] [Full Text] [Related]

  • 20. Pharmacology of quinpirole-stimulated [35S]GTPgammaS binding: discrepancy with receptor binding profile.
    Gilliland SL, Alper RH, Levant B.
    Eur J Pharmacol; 2000 Mar 31; 392(3):125-8. PubMed ID: 10762663
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.